- Home
- ONCY vs RPTX Comparison
ONCY vs RPTX Comparison
Compare ONCY & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- RPTX
- Stock Information
- Founded
- ONCY 1998
- RPTX 2016
- Country
- ONCY Canada
- RPTX Canada
- Employees
- ONCY N/A
- RPTX N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- RPTX Health Care
- Exchange
- ONCY Nasdaq
- RPTX Nasdaq
- Market Cap
- ONCY 106.1M
- RPTX 92.4M
- IPO Year
- ONCY 1999
- RPTX 2020
- Fundamental
- Price
- ONCY $0.99
- RPTX $2.20
- Analyst Decision
- ONCY Strong Buy
- RPTX Strong Buy
- Analyst Count
- ONCY 6
- RPTX 3
- Target Price
- ONCY $6.00
- RPTX $3.50
- AVG Volume (30 Days)
- ONCY 750.7K
- RPTX 1.1M
- Earning Date
- ONCY 11-12-2025
- RPTX 11-14-2025
- Dividend Yield
- ONCY N/A
- RPTX N/A
- EPS Growth
- ONCY N/A
- RPTX N/A
- EPS
- ONCY N/A
- RPTX N/A
- Revenue
- ONCY N/A
- RPTX $11,870,000.00
- Revenue This Year
- ONCY N/A
- RPTX N/A
- Revenue Next Year
- ONCY N/A
- RPTX N/A
- P/E Ratio
- ONCY N/A
- RPTX N/A
- Revenue Growth
- ONCY N/A
- RPTX N/A
- 52 Week Low
- ONCY $0.33
- RPTX $0.89
- 52 Week High
- ONCY $1.51
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- ONCY 39.40
- RPTX 66.44
- Support Level
- ONCY $0.97
- RPTX $2.10
- Resistance Level
- ONCY $1.05
- RPTX $2.30
- Average True Range (ATR)
- ONCY 0.06
- RPTX 0.08
- MACD
- ONCY 0.00
- RPTX 0.03
- Stochastic Oscillator
- ONCY 42.83
- RPTX 83.08
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.